
Sotera Health Company SHC
€ 14.60
2.12%
Land |
|
IPO-Jahr |
2020 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
284 M |
Marktkapitalisierung |
$ 4.65 B |
EBITDA (LTM) |
$ 22.4 M |
P/E (LTM) |
26.75 |
P/S (LTM) |
3.706042 |
EPS (LTM) |
0.6 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Natera
NTRA
|
$ 390.37 | 0.45 % | $ 53.4 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 31.09 | 9.24 % | $ 29.5 B | NYSE | ||
|
Myriad Genetics
MYGN
|
$ 6.01 | -0.58 % | $ 557 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 4.96 | 2.06 % | $ 3.9 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 17.11 | 1.66 % | $ 2.19 B | Nasdaq Global Select Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.79 | 4.07 % | $ 1.34 B | Nasdaq Global Select Market | ||
|
Pacific Biosciences of California
PACB
|
$ 2.51 | 2.66 % | $ 753 M | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 12.45 | 2.85 % | $ 2.71 B | Nasdaq Global Select Market,SPB | ||
|
Precipio
PRPO
|
$ 19.64 | 5.48 % | $ 31.5 M | Nasdaq Global Select Market | ||
|
Personalis
PSNL
|
$ 15.8 | 0.29 % | $ 1.41 B | Nasdaq Global Select Market | ||
|
Quidel Corporation
QDEL
|
$ 14.52 | 3.05 % | $ 612 M | Nasdaq Global Select Market,SPB | ||
|
VolitionRx Limited
VNRX
|
$ 0.2 | 5.65 % | $ 25.2 M | NYSE American | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Trinity Biotech plc
TRIB
|
$ 6.43 | -2.02 % | $ 2.31 B | Nasdaq Global Select Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 27.03 | 12.3 % | $ 605 M | Nasdaq Global Select Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 142.53 | 1.59 % | $ 8.52 B | Nasdaq Global Select Market,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Guardant Health
GH
|
$ 171.03 | -2.27 % | $ 21.4 B | Nasdaq Global Select Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Interpace Biosciences
IDXG
|
$ 5.72 | 5.1 % | $ 25.3 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 226.55 | -4.89 % | $ 35.1 B | Nasdaq Global Select Market,SPB | ||
|
Celcuity
CELC
|
$ 69.03 | -0.73 % | $ 3.23 B | Nasdaq Global Select Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 367.96 | 3.97 % | $ 30.6 B | NYSE,SPB | ||
|
Medpace Holdings
MEDP
|
$ 656.33 | -1.08 % | $ 18.9 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 332.3 | -5.56 % | $ 16.5 B | NYSE,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 723.68 | 1.51 % | $ 35.5 B | NYSE,SPB | ||
|
Castle Biosciences
CSTL
|
$ 35.78 | 1.82 % | $ 1.04 B | Nasdaq Global Market,SPB | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
$ 50.86 | 0.95 % | $ 11 B | NYSE | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 11.19 | 0.36 % | $ 380 M | Nasdaq Global Select Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 255.64 | 3.47 % | $ 28.4 B | NYSE,SPB | ||
|
Neuronetics
STIM
|
$ 2.69 | 19.03 % | $ 177 M | Nasdaq Global Select Market | ||
|
Waters Corporation
WAT
|
$ 470.44 | 2.29 % | $ 28 B | NYSE,SPB | ||
|
Exagen
XGN
|
$ 8.51 | 2.04 % | $ 183 M | Nasdaq Global Market | ||
|
Danaher Corporation
DHR
|
$ 235.76 | 2.46 % | $ 168 B | NYSE,SPB | ||
|
DexCom
DXCM
|
$ 88.86 | 7.1 % | $ 34.7 B | Nasdaq Global Select Market,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market |